SeaCrest Wealth Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-1,896
Closed -$85K – 864
2022
Q2
$85K Buy
+1,896
New +$97.3K 0.01% 919
2019
Q2
– Sell
-1,859
Closed -$86K – 878
2019
Q1
$86K Buy
1,859
+4
+0.2% +$203 0.01% 748
2018
Q4
$91K Buy
1,855
+2
+0.1% +$114 0.02% 687
2018
Q3
$115K Buy
1,853
+3
+0.2% +$182 0.02% 693
2018
Q2
$100K Buy
1,850
+2
+0.1% +$100 0.02% 720
2018
Q1
$84K Buy
+1,848
New +$79.2K 0.02% 762

Other funds holding EHC

SeaCrest Wealth Management's EHC Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Encompass Health (EHC) in Q3 2022, closing a stake of 1,896 shares — an estimated $85K sold.

SeaCrest Wealth Management first reported a position in EHC in Q1 2018 and held it in 6 quarters. The position peaked at $115K in Q3 2018. 346 funds tracked by Wall St. Rank hold EHC as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining Encompass Health position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 1,896 Encompass Health shares in Q3 2022, an estimated $85K.
  • SeaCrest Wealth Management first reported a position in Encompass Health in Q1 2018 and held it in 6 quarters.
  • SeaCrest Wealth Management's Encompass Health position peaked at $115K in Q3 2018.
  • 346 funds tracked by Wall St. Rank held Encompass Health as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.